Synthesis, Characterisation and Cytotoxic Studies of Novel Curcumin-Metformin Conjugate
1★, 1, 2★ Corresponding author
- 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, INDIA.
- 2Institute for Drug Delivery and Biomedical Research, Bengaluru, Karnataka, INDIA.
CORRESPONDENCE
Vijaybhanu Perumalsamy
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, Karnataka, INDIA.
Received: 23-09-2021; Revised: 25-10-2021; Accepted: 23-11-2021.
Volume 14, Issue 1 · pp. 73-76 · 2022 · DOI: 10.5530/jyp.2022.14.14
ABSTRACT
Background: Curcumin, chemically difeluroyl methane is a yellow polyphenol isolated from the rhizomes of perennial herb Curcuma longa. It has been shown highly cytotoxic towards various cancer cell lines but its water insolubility and instability make its bioavailability exceedingly low. Conjugation of curcumin with another drug increases the steric hindrance around the molecule and stabilizes it against chemical and enzymatic degradation. Metformin, chemically N, N’-dimethyl biguanide has been reported to exhibit anticancer potential by activating adenosine monophosphate activated protein kinase (AMPK) pathway.Methods: In the present work, novel curcumin-metformin conjugate was synthesised and evaluated for in vitro cytotoxic activity. It was prepared through a covalent bond between the phenolic hydroxyl group of curcumin and amino group of metformin using the linker succinic anhydride and by employing carbodiimide coupling agent dicylohexyl carbodiimide (DCC) in the presence of N-hydroxy succinimide (NHS). It was then characterized using IR, 1 HNMR and mass spectroscopy analysis. The stability of the synthesized conjugate was studied in acidic and basic pH conditions by UV spectroscopic method. In vitro anticancer potential of the synthesised conjugate was studied by MTT assay.Results: Curcumin-metformin conjugate exhibited enhanced stability as compared to curcumin. It was found to significantly increase the cytotoxicity against MCF-7 and PA-1 cells as compared to the free drugs.Conclusion: It can be concluded that the synthesized conjugate has better stability in the gastrointestinal tract than curcumin and has the potential for optimizing anticancer therapy.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Perumalsamy, V., DR, H. K., & Suresh, S. (2022). Synthesis, Characterisation and Cytotoxic Studies of Novel Curcumin-Metformin Conjugate. Journal of Young Pharmacists, 14(1), 73-76. https://doi.org/10.5530/jyp.2022.14.14
Copyright and licence
© 2022 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0